Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 54: 1432-1442, 2008. First published August 1, 2008; 10.1373/clinchem.2008.106138
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2008.106138v1
54/9/1432    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaffe, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaffe, A. S.
(Clinical Chemistry. 2008;54:1432-1442.)
© 2008 American Association for Clinical Chemistry, Inc.

Review

Key Issues in the Developing Synergism between Cardiovascular Imaging and Biomarkers

Allan S. Jaffe1

1 Mayo Clinic and Medical School, Rochester, MN.

aAddress correspondence to the author at: Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Fax 507-266-0228, e-mail jaffe.allan{at}mayo.edu.

Background: Sophisticated methods of cardiac imaging have the potential to revolutionize the care of patients with cardiovascular disease. The benefits of these state-of-the art imaging techniques can be enhanced by their use in combination with new cardiac biomarkers. This review addresses potentially useful interactions between imaging and biomarkers.

Content: Areas were defined in which the combined use of novel imaging techniques and biomarkers would be most beneficial. This review addresses multiple cardiovascular conditions for which the useful aspects of imaging and biomarkers are likely to be positively synergistic, including acute and chronic ischemic heart disease, heart failure, myocarditis, hypertension, and atherosclerosis.

Conclusions: The synergistic use of imaging techniques and biomarkers will enhance the investigation of many key issues and questions and will be an important resource in the future.




The following articles in journals at HighWire Press have cited this article:


Home page
 Eur J Heart FailHome page
M. Emdin, S. Vittorini, C. Passino, and A. Clerico
Old and new biomarkers of heart failure
Eur J Heart Fail, April 1, 2009; 11(4): 331 - 335.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.